Growth Metrics

Armata Pharmaceuticals (ARMP) Other Non-Current Liabilities (2016 - 2018)

Historic Other Non-Current Liabilities for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to $154000.0.

  • Armata Pharmaceuticals' Other Non-Current Liabilities fell 6150.0% to $154000.0 in Q3 2018 from the same period last year, while for Sep 2018 it was $154000.0, marking a year-over-year decrease of 6150.0%. This contributed to the annual value of $292000.0 for FY2017, which is 8804.75% down from last year.
  • Latest data reveals that Armata Pharmaceuticals reported Other Non-Current Liabilities of $154000.0 as of Q3 2018, which was down 6150.0% from $185000.0 recorded in Q2 2018.
  • In the past 5 years, Armata Pharmaceuticals' Other Non-Current Liabilities ranged from a high of $20.1 million in Q1 2014 and a low of $2000.0 during Q1 2016
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $1.5 million (2015), whereas its average is $3.9 million.
  • In the last 5 years, Armata Pharmaceuticals' Other Non-Current Liabilities crashed by 9998.64% in 2016 and then skyrocketed by 11635000.0% in 2017.
  • Armata Pharmaceuticals' Other Non-Current Liabilities (Quarter) stood at $5.8 million in 2014, then tumbled by 74.27% to $1.5 million in 2015, then soared by 62.98% to $2.4 million in 2016, then tumbled by 88.05% to $292000.0 in 2017, then plummeted by 47.26% to $154000.0 in 2018.
  • Its Other Non-Current Liabilities was $154000.0 in Q3 2018, compared to $185000.0 in Q2 2018 and $187000.0 in Q1 2018.